>2 years since the start of the #COVID19 pandemic, and we still don't have a treatment for #longCOVID 💊 In this paper, we assessed the impact of #SARSCoV2#vaccination on #longCOVID symptoms, and explored the immunological basis for any such effect. 💉https://t.co/rZOQuhbY7v
Our study on severe prolonged fatigue in a cohort of participants with mild to critical COVID-19 has been featured as #OFIDEditorsChoice 🦠 In this paper, we shed light on the occurrence of severe post-COVID fatigue and its risk factors. @AnoukVerveen@GGDAmsID
5/5 Studies including #COVID19-negative controls and those exploring the underlying pathogenesis of post-#COVID19 persistent severe fatigue are urgently needed to develop effective prevention and management strategies. @AnoukVerveen@GGDAmsID
Congrats @AnoukVerveen on leading this important editorial with multidisciplinary experts on setting a research agenda for post-#COVID#fatigue. Access: https://t.co/xc6kr8N5Z9
Focus on aetiology, functional impact, economic outcomes & interventions. https://t.co/ZXUdrlNPFZ
1/6🧵So far this week, we have looked at rates and risk factors of testing positive for #SARSCoV2 in Amsterdam. But what actually happens to those with #COVID19 over time? 🤒🤧
Body image in children with gender incongruence.
Article written by @AnoukVerveen, Kreukels, de Graaf & Steensma from Centre of Expertise on Gender Dysphoria and Department of Medical Psychology at @amsterdamumc. Read article here: https://t.co/TDpaWdR90d
A prospective cohort study in CID found that long-term COVID-19 symptoms were common, even in those with mild disease. Female and obese patients recovered more slowly, regardless of age or comorbidities.
📄: https://t.co/ByK2RVyXuD
#ClinInfectDis#IDSAJournals@epi_elks